Dudley Capital Management’s Pfizer PFE Stock Holding History

Dudley Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Buy	68,090 +36	+0.1%	+$942	0.66%	39
2026 Q1	$1.91M	Buy	68,054 +34	+0%	+$905	0.84%	32
2025 Q4	$1.69M	Buy	68,020 +584	+0.9%	+$14.7K	0.74%	34
2025 Q3	$1.72M	Sell	67,436 -3,648	-5%	-$90K	0.77%	34
2025 Q2	$1.72M	Sell	71,084 -215	-0.3%	-$5.01K	0.86%	33
2025 Q1	$1.81M	Buy	71,299 +15,768	+28%	+$413K	0.95%	32
2024 Q4	$1.47M	Sell	55,531 -637	-1%	-$17.3K	0.74%	38
2024 Q3	$1.63M	Sell	56,168 -2,400	-4%	-$70K	0.84%	34
2024 Q2	$1.64M	Buy	58,568 +25	+0%	+$688	0.91%	30
2024 Q1	$1.62M	Sell	58,543 -42	-0.1%	-$1.17K	0.95%	29
2023 Q4	$1.69M	Sell	58,585 -7,616	-12%	-$230K	1.08%	25
2023 Q3	$2.2M	Sell	66,201 -3,837	-5%	-$136K	1.54%	18
2023 Q2	$2.57M	Sell	70,038 -3,562	-5%	-$139K	1.73%	14
2023 Q1	$3M	Buy	73,600 +109	+0.1%	+$4.71K	2.04%	10
2022 Q4	$3.77M	Buy	+73,491	New	+$3.52M	2.64%	7

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Dudley Capital Management's PFE Position: Q2 2026 in Review

Dudley Capital Management increased its Pfizer (PFE) stake by 0.05% in Q2 2026, buying an estimated $942 and bringing the position to 68,090 shares worth $1.64M. The position accounts for 0.66% of the portfolio, ranked #39.

Dudley Capital Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.77M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Dudley Capital Management held 68,090 shares of Pfizer worth $1.64M as of Q2 2026.
Dudley Capital Management bought 36 Pfizer shares in Q2 2026, an estimated $942.
Pfizer made up 0.66% of Dudley Capital Management's portfolio in Q2 2026, its #39 holding.
Dudley Capital Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Dudley Capital Management's Pfizer position peaked at $3.77M in Q4 2022.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.